Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-02 McLaughlin Melissa Chief Human Resources Officer Sale 10b5-1 −359 $317.44 $114K 12,729
2026-04-02 McLaughlin Melissa Chief Human Resources Officer Sale 10b5-1 −209 $318.47 $67K 12,520
2026-04-02 McLaughlin Melissa Chief Human Resources Officer Sale 10b5-1 −86 $319.69 $27K 12,434
2026-04-02 McLaughlin Melissa Chief Human Resources Officer Sale 10b5-1 −147 $320.62 $47K 12,287
2026-04-02 McLaughlin Melissa Chief Human Resources Officer Sale 10b5-1 −224 $321.64 $72K 12,063
2026-04-02 McLaughlin Melissa Chief Human Resources Officer Sale 10b5-1 −245 $322.86 $79K 11,818
2026-04-02 McLaughlin Melissa Chief Human Resources Officer Sale 10b5-1 −81 $323.64 $26K 11,737
2026-04-02 McLaughlin Melissa Chief Human Resources Officer Sale 10b5-1 −8 $325.49 $3K 11,729
2026-03-05 Garg Pushkal EVP Chief R&D Sale 10b5-1 −654 $322.33 $211K 20,443
2026-03-05 Garg Pushkal EVP Chief R&D Sale 10b5-1 −740 $323.55 $239K 19,703
2026-03-05 Garg Pushkal EVP Chief R&D Sale 10b5-1 −510 $324.59 $166K 19,193
2026-03-05 Garg Pushkal EVP Chief R&D Sale 10b5-1 −500 $326.08 $163K 18,693
2026-03-05 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −124 $321.81 $40K 21,103
2026-03-05 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −233 $323.25 $75K 20,870
2026-03-05 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −148 $324.60 $48K 20,722
2026-03-05 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −153 $326.24 $50K 20,569
2026-03-04 Garg Pushkal EVP Chief R&D Sale 10b5-1 −106 $319.03 $34K 23,300
2026-03-04 Garg Pushkal EVP Chief R&D Sale 10b5-1 −102 $320.01 $33K 23,198
2026-03-04 Garg Pushkal EVP Chief R&D Sale 10b5-1 −215 $320.81 $69K 22,983
2026-03-04 Garg Pushkal EVP Chief R&D Sale 10b5-1 −289 $321.82 $93K 22,694

Page 3 of 41 · 816 trades